ARC39MRTX1133pancreatic ductal adenocarcinomacancerPDAC
…ependent sphingolipid metabolism. Notably, the SMPD1 inhibitor (ARC39) potently synergised with the KrasG12D inhibitor (MRTX1133).Con…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ARC39 ×
ARC39
This drug is selected. Its supporting articles are shown below.